Literature DB >> 3017996

Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transport.

J M Hardwick, K E Shaw, J W Wills, E Hunter.   

Abstract

Protein sequence requirements for cleavage of the signal peptide from the Rous sarcoma virus glycoprotein have been investigated through the use of deletion mutagenesis. The phenotypes of these mutants have been characterized by expression of the cloned, mutated env genes in CV-1 cells using a late replacement SV40 vector. The deletion mutations were generated by Ba131 digestion at the XhoI site located near the 5' end of the coding sequence for the structural protein gp85, which is found at the amino terminus of the precursor glycoprotein, Pr95. The results of experiments with three mutants (X1, X2, and X3) are presented. Mutant X1 has a 14 amino acid deletion encompassing amino acids 4-17 of gp85, which results in the loss of one potential glycosylation site. In mutants X2 and X3 the amino terminal nine and six amino acids, respectively, of gp85 are deleted. During the biosynthesis of all three mutant polypeptides, the signal peptide is efficiently and accurately cleaved from the nascent protein, even though in mutants X2 and X3 the cleavage site itself has been altered. In these mutants the alanine/aspartic acid cleavage site has been mutated to alanine/asparagine and alanine/glutamine, respectively. These results are consistent with the concept that sequences C-terminal to the signal peptidase site are unimportant in defining the site of cleavage in eucaryotes. Mutants X2 and X3 behave like wild-type with respect to protein glycosylation, palmitic acid addition, cleavage to gp85 and gp37, and expression on the cell surface. Mutant X1, on the other hand, is defective in intracellular transport. Although it is translocated across the rough endoplasmic reticulum and core-glycosylated, its transport appears to be blocked at an early Golgi compartment. No terminal glycosylation of the protein, cleavage of the precursor protein to the mature products, or expression on the cell surface is observed. The deletion in X1 thus appears to destroy signals required for export to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017996      PMCID: PMC2114272          DOI: 10.1083/jcb.103.3.829

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  44 in total

1.  Pathways of protein secretion in eukaryotes.

Authors:  R B Kelly
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

2.  Rous sarcoma virus mutant LA3382 is defective in virion glycoprotein assembly.

Authors:  J M Hardwick; E Hunter
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

3.  Isolation of the Escherichia coli leader peptidase gene and effects of leader peptidase overproduction in vivo.

Authors:  T Date; W Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  Localization and processing of outer membrane and periplasmic proteins in Escherichia coli strains harboring export-specific suppressor mutations.

Authors:  S D Emr; P J Bassford
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

5.  Mechanism of signal peptide cleavage in the biosynthesis of the major lipoprotein of the Escherichia coli outer membrane.

Authors:  M Hussain; S Ichihara; S Mizushima
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

Review 6.  Synthesis and processing of asparagine-linked oligosaccharides.

Authors:  S C Hubbard; R J Ivatt
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

7.  Processing of filamentous phage pre-coat protein. Effect of sequence variations near the signal peptidase cleavage site.

Authors:  J D Boeke; M Russel; P Model
Journal:  J Mol Biol       Date:  1980-12-05       Impact factor: 5.469

8.  Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene.

Authors:  M J Gething; J Sambrook
Journal:  Nature       Date:  1981-10-22       Impact factor: 49.962

9.  Membrane-bound penicillinases in Gram-positive bacteria.

Authors:  J B Nielsen; J O Lampen
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

Review 10.  Mechanisms for the incorporation of proteins in membranes and organelles.

Authors:  D D Sabatini; G Kreibich; T Morimoto; M Adesnik
Journal:  J Cell Biol       Date:  1982-01       Impact factor: 10.539

View more
  9 in total

1.  Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.

Authors:  I Lax; F Bellot; A M Honegger; A Schmidt; A Ullrich; D Givol; J Schlessinger
Journal:  Cell Regul       Date:  1990-01

2.  Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.

Authors:  R A Olmsted; B R Murphy; L A Lawrence; N Elango; B Moss; P L Collins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Adenovirus preterminal protein synthesized in COS cells from cloned DNA is active in DNA replication in vitro.

Authors:  S C Pettit; M S Horwitz; J A Engler
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Oligomeric structure of a prototype retrovirus glycoprotein.

Authors:  D Einfeld; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons.

Authors:  L Perez; J W Wills; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.

Authors:  J M Hardwick; P M Lieberman; S D Hayward
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

9.  Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.

Authors:  P A Bresnahan; R Leduc; L Thomas; J Thorner; H L Gibson; A J Brake; P J Barr; G Thomas
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.